Bivariable | Multivariable | |||||
Model 1 | Model 2 | |||||
Factor | OR | 95%CI | OR | 95%CI | OR | 95%CI |
Sex (Male) | 1.34 | 0.99 - 1.82 | ||||
Age | 1.00 | 0.99 - 1.02 | ||||
BMI | 1.11 | 0.83 - 1.50 | ||||
HbA1c | 4.06* | 3.28 - 5.04 | 3.86* | 2.41 - 6.17 | 3.88* | 2.44 - 6.17 |
HOMA-R☨ | 1.18 | 0.93 - 1.49 | ||||
HOMA-β☨ | 0.49* | 0.38 - 0.65 | 0.83 | 0.53 - 1.29 | ||
Proinsulin/Insulin ratio☨ | 2.45* | 1.50 - 4.00 | 1.63 | 0.86 - 3.11 | ||
1,5-AG☨ | 0.32* | 0.24 - 0.44 | 0.91 | 0.54 - 1.55 | 0.89 | 0.53 - 1.50 |
Adiponectin☨ | 0.86 | 0.65 - 1.13 | ||||
Combination with | ||||||
Sulfonylurea | 2.41* | 1.79 - 3.26 | 1.13 | 0.60 - 2.15 | 1.15 | 0.61 - 2.18 |
α-Glucosidase inhibitor | 3.26* | 2.09 - 5.08 | 3.25* | 1.40 - 7.53 | 3.22* | 1.38 - 7.50 |
Biguanide | 1.39** | 1.04 - 1.85 | 1.29 | 0.71 - 2.34 | 1.25 | 0.69 - 2.28 |
Glinide | 1.76 | 0.57 - 5.43 | ||||
Thiazolidinedione | 1.45 | 0.93 - 2.28 |